| STK004268 | COc1ccc(cc1[N+](=O)[O-])C(=O)Nc1ccc(cc1)NC(=O)c1cccc(c1)C | 4-methoxy-N-(4-{[(3-methylphenyl)carbonyl]amino}phenyl)-3-nitrobenzamide | C22H19N3O5 | 405.41 g/mol |
| STK004269 | O=C(NNS(=O)(=O)c1ccc(cc1)Cl)CCC(=O)Nc1ccccc1 | 4-{2-[(4-chlorophenyl)sulfonyl]hydrazinyl}-4-oxo-N-phenylbutanamide | C16H16ClN3O4S | 381.84 g/mol |
| STK004270 | CCOc1cc(ccc1OCC)C(=O)Nc1ccc(cc1)Br | N-(4-bromophenyl)-3,4-diethoxybenzamide | C17H18BrNO3 | 364.24 g/mol |
| STK004271 | Clc1ccc(c(c1)Cl)OCC(=O)N(C1(CCCC1)C(=O)Nc1cccc(c1)C)Cc1ccco1 | 1-{[(2,4-dichlorophenoxy)acetyl](furan-2-ylmethyl)amino}-N-(3-methylphenyl)cyclopentanecarboxamide | C26H26Cl2N2O4 | 501.41 g/mol |
| STK004272 | O=C1NC(=NC(C1)C(=O)Nc1ccc(cc1C)Cl)Nc1nc2c(s1)cccc2 | 2-(1,3-benzothiazol-2-ylamino)-N-(4-chloro-2-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyrimidine-4-carboxamide | C19H16ClN5O2S | 413.89 g/mol |
| STK004273 | S=C(Nc1cc(Cl)ccc1Cl)NC(=O)c1ccc(c(c1)C)C | N-[(2,5-dichlorophenyl)carbamothioyl]-3,4-dimethylbenzamide | C16H14Cl2N2OS | 353.27 g/mol |
| STK004274 | Brc1ccc(cc1)C(=O)Nc1cc(Cl)c(cc1Cl)Cl | 4-bromo-N-(2,4,5-trichlorophenyl)benzamide | C13H7BrCl3NO | 379.47 g/mol |
| STK004275 | COc1ccccc1c1nn2c(n1)c1c(nc2)sc2c1CCCC2 | 2-(2-methoxyphenyl)-8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine | C18H16N4OS | 336.42 g/mol |
| STK004276 | Clc1ccc(c(c1)c1ccc(o1)C(=O)Nc1cccc(c1)NC(=O)c1ccccc1)Cl | 5-(2,5-dichlorophenyl)-N-{3-[(phenylcarbonyl)amino]phenyl}furan-2-carboxamide | C24H16Cl2N2O3 | 451.31 g/mol |
| STK004277 | COc1ccc(cc1C(=O)Nc1ccc(cc1C(=O)O)Br)[N+](=O)[O-] | 5-bromo-2-{[(2-methoxy-5-nitrophenyl)carbonyl]amino}benzoic acid | C15H11BrN2O6 | 395.17 g/mol |
| STK004278 | CCOc1ccc2c(c1)sc(n2)SCC(=O)NCc1ccco1 | 2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-N-(furan-2-ylmethyl)acetamide | C16H16N2O3S2 | 348.45 g/mol |
| STK004279 | COCC1=C(C(=O)OC)C(C(=C(O1)N)C#N)c1ccncc1 | methyl 6-amino-5-cyano-2-(methoxymethyl)-4-(pyridin-4-yl)-4H-pyran-3-carboxylate | C15H15N3O4 | 301.30 g/mol |
